Display options
Share it on

Front Microbiol. 2015 Aug 24;6:875. doi: 10.3389/fmicb.2015.00875. eCollection 2015.

Variation in the nuclear effects of infection by different human rhinovirus serotypes.

Frontiers in microbiology

Erin J Walker, Lora M Jensen, Sarah Croft, Reena Ghildyal

Affiliations

  1. Centre for Research in Therapeutic Solutions, Faculty of Education, Science, Technology and Mathematics, University of Canberra, Canberra ACT, Australia.

PMID: 26379650 PMCID: PMC4547043 DOI: 10.3389/fmicb.2015.00875

Abstract

Human rhinovirus (HRV) is a positive sense RNA virus, which, despite replicating in the cytoplasm, has a significant impact on nuclear transport and nuclear localization of host proteins. A number of studies have identified differences between HRV serotypes, with respect to host response, protease activity and replicative ability. Here we report the sero-specific effects of two group-A HRV serotypes, the minor group HRV2 and the major group HRV16, on nuclear transport and nuclear protein localization. Using Western analysis, immunofluorescence and real time PCR, we show that HRV2 replicates at a faster rate than HRV16, which correlates with earlier production of viral proteases and disruption of host nuclear transport. There is significant variation in the nuclear effects of different rhinovirus species, which in turn may impact disease progression and patient response.

Keywords: human rhinovirus; nuclear transport; nucleoporin; serotype; viral proteases

References

  1. Proc Natl Acad Sci U S A. 1996 Mar 19;93(6):2296-301 - PubMed
  2. J Allergy Clin Immunol. 2014 Aug;134(2):332-41 - PubMed
  3. J Virol. 1993 Jul;67(7):3798-807 - PubMed
  4. PLoS One. 2013 Aug 07;8(8):e71316 - PubMed
  5. PLoS One. 2014 Dec 12;9(12):e114322 - PubMed
  6. Biochem Biophys Res Commun. 2003 Jan 24;300(4):950-6 - PubMed
  7. J Virol Methods. 2004 May;117(2):113-21 - PubMed
  8. J Virol. 2015 Feb;89(3):1939-43 - PubMed
  9. Biochemistry. 1993 Jul 27;32(29):7581-8 - PubMed
  10. J Virol. 2011 Oct;85(20):10874-83 - PubMed
  11. Science. 2009 Apr 3;324(5923):55-9 - PubMed
  12. Am J Respir Crit Care Med. 2012 Nov 1;186(9):886-91 - PubMed
  13. J Cell Biol. 1996 Sep;134(6):1365-73 - PubMed
  14. J Virol. 2002 Sep;76(17 ):8787-96 - PubMed
  15. J Virol. 1990 Mar;64(3):1117-23 - PubMed
  16. J Infect Dis. 2011 Dec 1;204(11):1702-10 - PubMed
  17. MBio. 2012 Feb 07;3(1):null - PubMed
  18. Mol Cell Biol. 2004 Feb;24(4):1779-90 - PubMed
  19. J Med Virol. 2005 Apr;75(4):608-15 - PubMed
  20. Virus Res. 1998 Jan;53(1):39-51 - PubMed
  21. Am J Respir Crit Care Med. 2011 Nov 1;184(9):1007-14 - PubMed
  22. Nat Med. 2011 Aug 14;17(9):1132-5 - PubMed
  23. Biochem Soc Trans. 2010 Aug;38(4):1116-21 - PubMed
  24. J Biol Chem. 1993 Sep 15;268(26):19200-3 - PubMed
  25. EMBO J. 2001 Jan 15;20(1-2):240-9 - PubMed
  26. PLoS One. 2014 Apr 15;9(4):e93897 - PubMed
  27. Respirology. 2009 Mar;14(2):180-6 - PubMed
  28. J Virol. 2012 Feb;86(3):1449-57 - PubMed
  29. J Virol. 2005 Jun;79(12):7389-95 - PubMed
  30. J Virol. 2015 Apr;89(8):4527-38 - PubMed
  31. J Gen Virol. 2004 Oct;85(Pt 10):2969-79 - PubMed
  32. J Biol Chem. 2001 Jun 29;276(26):23922-8 - PubMed

Publication Types